CNTA
Centessa Pharmaceuticals
CNTA
CNTA
145 hedge funds and large institutions have $3.6B invested in Centessa Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 48 increasing their positions, 44 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
11.11% more ownership
Funds ownership: 95.83% → 106.94% (+11%)
9% more funds holding in top 10
Funds holding in top 10: 11 → 12 (+1)
9% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 44
Holders
145
Holding in Top 10
12
Calls
$10.5M
Puts
$6.52M
Top Buyers
| 1 | +$94.9M | |
| 2 | +$68M | |
| 3 | +$65M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$55.4M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$50.7M |
Top Sellers
| 1 | -$90.3M | |
| 2 | -$46.9M | |
| 3 | -$34.4M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$33.3M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$26M |
